IPO13 and asthma: To assess whether common IPO13 DNA sequence variants influence treatment response to inhaled corticosteroids, we genotyped 10 common IPO13 variants in a cohort of children with asthma participating in a clinical trial evaluating the long-term efficacy of inhaled anti-inflammatory medication (including budesonide, a commonly prescribed inhaled GC)[17].